HUMAW

Humacyte Warrant (HUMAW)

About Humacyte Warrant (HUMAW)

Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.

Details

Daily high
$2.16
Daily low
$1.84
Price at open
$2.16
52 Week High
$3.47
52 Week Low
$0.35
Market cap
--
Dividend yield
0.00%
Volume
7,739
Avg. volume
29,677
P/E ratio
--

Humacyte Warrant News

Details

Daily high
$2.16
Daily low
$1.84
Price at open
$2.16
52 Week High
$3.47
52 Week Low
$0.35
Market cap
--
Dividend yield
0.00%
Volume
7,739
Avg. volume
29,677
P/E ratio
--